FDA

What Tomorrow Holds for U.S. Health Care

What Tomorrow Holds for U.S. Health Care

Experts offer solutions to pressing issues in American health care.

Determining How to Regulate Encapsulated Placenta

Determining How to Regulate Encapsulated Placenta

Scholar argues that FDA should use a narrowly tailored framework to regulate encapsulated placenta pills.

Got Soy Beverage?

Got Soy Beverage?

Plant-based milk producers may soon no longer be able to put “milk” on their labels.

Regulations Coming Soon for Lab-Grown Meat

Regulations Coming Soon for Lab-Grown Meat

FDA and USDA’s plan to jointly regulate lab-made meat raises new questions for the future of food regulation.

The Case for Eating Bugs

The Case for Eating Bugs

Scholar argues FDA should regulate insects as food to help address food insecurity.

How FDA Drug Review Contributed to the Opioid Epidemic

How FDA Drug Review Contributed to the Opioid Epidemic

Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.

Reforming Regulation to Promote Medical Use of Psychedelic Drugs

Reforming Regulation to Promote Medical Use of Psychedelic Drugs

Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.

Keeping Fraudulent Shrimp Out of Your Cocktail

Keeping Fraudulent Shrimp Out of Your Cocktail

The U.S. government is clamping down on seafood fraud and illegal fishing for shrimp imports.

The Medical Marijuana Delusion

The Medical Marijuana Delusion

Regulation of marijuana has been based on a false distinction for almost a century.

“Right to Try” Marks New Era in the Treatment of Terminally Ill Patients

“Right to Try” Marks New Era in the Treatment of Terminally Ill Patients

The Right to Try Act represents an important step toward helping dying patients with little recourse.

Groups of a Feather Regulate Together

Groups of a Feather Regulate Together

A flock of regulators and industry representatives have a seat at the turkey-regulating table.

Proposed Rule Aims to Make Drug Pricing More Transparent

Proposed Rule Aims to Make Drug Pricing More Transparent

A proposed requirement to display drug list prices in advertisements draws controversy.